BioXcel Therapeutics (BTAIQ) Accumulated Depreciation (2017 - 2026)
BioXcel Therapeutics' Accumulated Depreciation came in at $1.88 million for Q2 2026, up 13.6% from $1.65 million a year earlier and up 1.0% from the prior quarter.
BioXcel Therapeutics (BTAIQ) Accumulated Depreciation (2017 - 2026) Analysis & Trends
At the end of FY2025, BioXcel Therapeutics' Accumulated Depreciation was $1.8 million, up 20.0% from FY2024.
- Accumulated Depreciation has increased in each of the last seven years, with a five-year compound annual growth rate of 37.9% (FY2020 to FY2025).
- Going back by year, Accumulated Depreciation was $1.5 million in FY2024 (+25.9%), $1.19 million in FY2023 (+34.8%), $885,000 in FY2022 (+47.0%) and $602,000 in FY2021 (+66.3%).
- The Q2 2026 figure represents the highest quarterly Accumulated Depreciation in data going back to Q4 2017.
- Year-over-year, Accumulated Depreciation has increased for 27 consecutive quarters, with growth averaging 21.7% over the last eight quarters.
- The year-over-year growth in Accumulated Depreciation has ranged between 13.6% (Q2 2026) and 66.3% (Q4 2021) over the last five years.
- Business Quant data shows BTAIQ's Accumulated Depreciation at $1.86 million (Q1 2026), $1.8 million (Q4 2025) and $1.73 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 965,000.00 |
| Dec 31, 2022 | 885,000.00 |
| Sep 30, 2022 | 848,000.00 |
| Jun 30, 2022 | 763,000.00 |
| Mar 31, 2022 | 679,000.00 |
| Dec 31, 2021 | 602,000.00 |
| Sep 30, 2021 | 526,000.00 |
BioXcel Therapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();